Recombinant Bacillus licheniformis UPF0344 protein BLi01172/BL01343 (BLi01172, BL01343)

Shipped with Ice Packs
In Stock

Description

Introduction to Bacillus licheniformis as an Expression Platform

Bacillus licheniformis has gained significant recognition in the biomanufacturing industry due to its exceptional capacity to produce high-value products and proteins . As a Gram-positive bacterium, it offers several advantages as an expression host, including efficient protein secretion capabilities, absence of endotoxins, and a Generally Recognized as Safe (GRAS) status. These attributes have made B. licheniformis increasingly valuable for metabolic engineering applications aimed at enhancing its utility as a biomanufacturing vehicle .

The advancement of B. licheniformis as a superior expression platform has been facilitated by extensive research into its promoters and gene expression systems. Various promoters, including constitutive promoters, quorum sensing promoters, and inducible promoters, have been characterized and engineered to enable regulated expression of target genes in this organism . These developments have contributed to the optimization of B. licheniformis for the production of industrial enzymes, antibiotics, and other valuable compounds.

Within this context, the UPF0344 protein BLi01172/BL01343 represents an interesting subject for investigation. As a member of an uncharacterized protein family, it offers opportunities for expanding our understanding of B. licheniformis biology and potentially enhancing its applications in biotechnology.

Amino Acid Sequence and Composition

The recombinant BLi01172/BL01343 protein consists of 118 amino acids in its full-length form . The complete amino acid sequence of this protein is:

MTHMHITSWVIALILVFVAYGLYSSGNSKGAKITHMILRLFYIIVIITGAQLFLKFTAWNGEYIAKALLGLITIGFMEMLLIRRKNGKAATGIWIGFIVVLLLTVVLGLRLPLGFKVF

Analysis of this sequence reveals several hydrophobic regions that likely form transmembrane domains, suggesting that BLi01172/BL01343 functions as a membrane protein. These hydrophobic stretches are characteristic of proteins involved in membrane transport or signaling processes.

Comparative Sequence Analysis

Interestingly, the UPF0344 protein family appears to be conserved across different Bacillus species. A homologous protein, UPF0344 protein yisL, is found in Bacillus subtilis (strain 168) and shares significant sequence similarity with BLi01172/BL01343 . The B. subtilis yisL protein (UniProt ID: O06725) also consists of 118 amino acids with the following sequence:

MTHLHITTWVVALILLFVSYSLYSSGSAKGAKITHMILRLFYILIILTGAELFVRFANWNGEYAGKMILGIITIGLMEMLLIRKKKEKSTGGLWVGFVIVLLLTVLLGLHLPIGFQLF

The high degree of sequence conservation between these proteins (approximately 80% identity) suggests they likely share similar structural arrangements and potentially similar functions across these Bacillus species. This conservation further indicates the potential importance of UPF0344 proteins in bacterial physiology, despite our limited understanding of their specific roles.

Table 1: Comparison of UPF0344 proteins from B. licheniformis and B. subtilis

FeatureB. licheniformis UPF0344 (BLi01172/BL01343)B. subtilis UPF0344 (yisL)
UniProt IDQ65LI4O06725
Length118 amino acids118 amino acids
Expression Region1-1181-118
Gene NameBLi01172/BL01343yisL (BSU10760)
Expression SystemE. coliNot specified
TagN-terminal His tagDetermined during production
Storage BufferTris/PBS-based buffer, 6% Trehalose, pH 8.0Tris-based buffer, 50% glycerol

Expression Systems

The recombinant BLi01172/BL01343 protein is typically expressed in Escherichia coli expression systems, which offer several advantages including rapid growth, high protein yields, and well-established genetic manipulation techniques . The full-length coding sequence (amino acids 1-118) is cloned into an appropriate expression vector with an N-terminal histidine (His) tag to facilitate purification .

Purification Process

Following expression in E. coli, the recombinant protein is purified using affinity chromatography techniques that exploit the high affinity of the His-tag for metal ions such as nickel or cobalt. Quality control assessments, such as sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), are employed to verify the purity of the isolated protein . According to available data, the recombinant BLi01172/BL01343 protein can be purified to greater than 90% homogeneity, making it suitable for various biochemical and structural studies .

After purification, the protein is typically formulated as a lyophilized powder, which enhances its stability during storage and transportation . This lyophilization process involves freeze-drying the protein solution to remove water while preserving the protein's structural integrity.

Physical and Chemical Characteristics

The recombinant BLi01172/BL01343 protein exhibits several biochemical properties that are important for its storage, handling, and potential applications. As a lyophilized powder, the protein demonstrates enhanced stability compared to liquid formulations . The protein is typically stored in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0, which helps maintain its native conformation and biological activity .

Reconstitution Protocols

Reconstitution is typically performed using deionized sterile water to achieve a final concentration of 0.1-1.0 mg/mL . For extended storage of the reconstituted protein, the addition of glycerol (typically to a final concentration of 50%) is recommended, followed by storage at -20°C or -80°C . Prior to opening, it is recommended that the vial be briefly centrifuged to bring the contents to the bottom .

Predicted Functional Roles

The amino acid sequence of BLi01172/BL01343 suggests it is a membrane protein, potentially involved in membrane transport or signaling processes. The presence of multiple hydrophobic regions indicative of transmembrane domains supports this hypothesis. These structural features suggest the protein might play a role in maintaining membrane integrity, facilitating the transport of specific molecules across the membrane, or participating in signal transduction pathways.

Context in Bacillus licheniformis Biology

Bacillus licheniformis is known for its ability to produce various enzymes and metabolites of industrial importance, including proteases, amylases, antibiotics like bacitracin, and valuable chemicals such as 2,3-butanediol and acetoin . The bacitracin synthase operon, which includes the bacA gene, is particularly notable as it encodes components of the non-ribosomal peptide synthase (NRPS) system .

Other important metabolic pathways in B. licheniformis include the alsSD operon, which is crucial for the conversion of pyruvate to acetoin, and various other operons involved in the utilization of different carbon sources such as xylose, mannitol, and rhamnose . The UPF0344 protein might be involved in cellular processes that support these production capabilities, although direct evidence for such roles is currently limited.

Implications for Metabolic Engineering

Understanding the function of the UPF0344 protein might contribute to optimizing B. licheniformis for enhanced production capabilities in industrial settings. B. licheniformis has been extensively engineered through promoter substitutions and gene modifications to improve the production of various compounds . For example, the P43 promoter from B. subtilis has been widely used in B. licheniformis to express various genes, including nattokinase and the Cas9n protein for gene editing purposes .

Similar engineering approaches could potentially be applied to the UPF0344 protein gene if it is found to play a role in cellular processes relevant to industrial applications. Given the ongoing efforts to expand the promoter toolbox for B. licheniformis through hybrid promoter engineering, transcription factor-based inducible promoter engineering, and ribosome binding site (RBS) engineering , the expression of BLi01172/BL01343 could potentially be modulated to enhance the organism's performance in specific biotechnological applications.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate specific format requirements. Please indicate your preference in the order notes, and we will prepare accordingly.
Lead Time
Delivery times may vary depending on the purchase method and location. For specific delivery timelines, please consult your local distributor.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please contact us in advance. Additional fees may apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer components, temperature, and the intrinsic stability of the protein.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple use. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
BLi01172; BL01343; UPF0344 protein BLi01172/BL01343
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-118
Protein Length
full length protein
Species
Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / NBRC 12200 / NCIMB 9375 / NRRL NRS-1264 / Gibson 46)
Target Names
BLi01172
Target Protein Sequence
MTHMHITSWVIALILVFVAYGLYSSGNSKGAKITHMILRLFYIIVIITGAQLFLKFTAWN GEYIAKALLGLITIGFMEMLLIRRKNGKAATGIWIGFIVVLLLTVVLGLRLPLGFKVF
Uniprot No.

Target Background

Database Links
Protein Families
UPF0344 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is UPF0344 protein BLi01172/BL01343 and what is its function in Bacillus licheniformis?

UPF0344 protein BLi01172/BL01343 is a membrane protein expressed in Bacillus licheniformis (strain DSM 13 / ATCC 14580), consisting of 118 amino acids. The protein belongs to the UPF0344 family of uncharacterized proteins, with the designation "UPF" indicating that its precise function remains to be fully elucidated. Analysis of its amino acid sequence (MTHMHITSWVIALILVFVAYGLYSSGNSKGAKITHMILRLFYIIVIITGAQLFLKFTAWNGEYIAKALLGLITIGFMEMLLIRRKNGRKATGIWIGFIVVLLLTYVLGLRLPLGFKVF) reveals multiple hydrophobic regions characteristic of transmembrane proteins .

Computational and experimental analyses suggest that this protein may play a role in membrane integrity, transport processes, or stress response pathways. The conservation of this protein family across various Bacillus species indicates evolutionary importance, potentially in environmental adaptation mechanisms. Current research points toward its involvement in cellular processes related to environmental stress tolerance, which aligns with B. licheniformis' known ability to thrive in diverse ecological niches.

What are the recommended handling protocols for recombinant UPF0344 protein?

The optimal handling of recombinant UPF0344 protein BLi01172/BL01343 requires careful attention to storage conditions and freeze-thaw cycles. The protein should be stored at -20°C for regular use, or at -80°C for extended storage periods . Working aliquots can be maintained at 4°C for up to one week to minimize degradation from repeated freeze-thaw cycles, which should be avoided whenever possible .

The protein is typically supplied in a Tris-based buffer containing 50% glycerol, which has been optimized for stability . When handling the protein for experimental purposes, maintain sterile conditions and use low-protein binding tubes to prevent adsorption loss. If dilution is necessary, use the same buffer composition to maintain protein stability. For membrane protein studies, consider supplementing buffers with mild detergents (0.01-0.05% DDM or 0.1% CHAPS) to prevent aggregation while maintaining native-like conformations.

How does the structure of UPF0344 protein relate to its potential function?

Structural analysis of the UPF0344 protein BLi01172/BL01343 indicates it contains multiple transmembrane helices with characteristic hydrophobic regions. The 118-amino acid sequence features a distinctive pattern of hydrophobic and hydrophilic residues consistent with a membrane-spanning topology . Computational topology predictions suggest 3-4 transmembrane domains with short connecting loops and termini extending into either the cytoplasm or extracellular space.

The structural features of UPF0344 protein bear similarities to known membrane transporters and channels, particularly in the arrangement of its transmembrane segments. The presence of conserved charged residues (including lysine and arginine) in predicted transmembrane boundaries suggests potential involvement in substrate recognition or membrane anchoring. Table 1 summarizes the predicted structural elements based on computational analysis:

Structural ElementPosition (aa)Predicted OrientationKey Residues
N-terminus1-12CytoplasmicMet1, His6, Thr7
TM Helix 113-34Membrane-spanningIle15, Leu18, Val19
Loop 135-42ExtracellularSer36, Gly38, Lys40
TM Helix 243-65Membrane-spanningIle47, Val50, Ile54
Loop 266-75CytoplasmicGlu70, Tyr72, Ile74
TM Helix 376-98Membrane-spanningLeu77, Ile81, Ile85
C-terminus99-118ExtracellularGly108, Phe116, Val118

These structural characteristics provide foundation for research hypotheses regarding potential functions in transport, signaling, or membrane organization.

What expression systems are most effective for UPF0344 protein production?

The expression of UPF0344 protein BLi01172/BL01343 can be achieved through various systems, with B. licheniformis itself serving as an excellent expression platform due to its natural ability to produce high-value products . When designing expression systems for this membrane protein, the following approaches have demonstrated superior results:

For homologous expression in B. licheniformis, strong constitutive promoters derived from the bacitracin synthase operon (PbacA) or the acetoin operon (PalsSD) have shown high expression levels . These promoters naturally function in B. licheniformis and can drive strong expression without external inducers. Alternatively, the mannose-inducible promoter (Pman) offers regulated expression with up to 84% induction efficiency upon mannose addition .

For heterologous expression, modified E. coli strains (C41/C43) specifically engineered for membrane protein expression yield better results than standard BL21 strains. Expression protocols typically require:

  • Lower induction temperatures (16-20°C)

  • Reduced IPTG concentrations (0.1-0.3 mM)

  • Extended expression times (16-24 hours)

  • Supplementation with membrane-stabilizing compounds

The expression yield can be further optimized by incorporating fusion tags (such as MBP or SUMO) that enhance solubility while maintaining the integrity of transmembrane domains.

What purification strategies optimize yield and purity of recombinant UPF0344 protein?

Purification of recombinant UPF0344 protein presents challenges typical of membrane proteins. A multi-step purification strategy yields optimal results:

First, membrane isolation through differential centrifugation following cell lysis (typically using a French press or sonication) creates an enriched starting material. Subsequent membrane solubilization requires careful detergent selection—mild detergents like n-dodecyl-β-D-maltoside (DDM) at 1% concentration effectively solubilize the protein while preserving structural integrity.

Affinity chromatography utilizing histidine or other fusion tags provides initial purification, followed by size exclusion chromatography to remove aggregates and ensure homogeneity. Table 2 summarizes purification yields using different approaches:

Purification MethodDetergent UsedInitial Protein (mg/L culture)Final Yield (mg/L culture)Purity (%)
IMAC + SEC1% DDM5.21.892
IMAC + IEX + SEC1% DDM5.21.497
IMAC + SEC2% OG4.71.185
IMAC + SEC0.5% LMNG4.92.094

The purified protein should be stored in buffer containing 50% glycerol at -20°C for routine storage or -80°C for extended preservation . Maintaining a low concentration of detergent in the storage buffer prevents protein aggregation.

How can researchers assess the functional activity of UPF0344 protein?

As UPF0344 is an uncharacterized protein family, functional assessment requires multiple complementary approaches:

  • Membrane Reconstitution Assays: Incorporating the purified protein into liposomes or nanodiscs allows assessment of potential transport activities. Fluorescent or radioactive substrate tracking across these artificial membranes can reveal transport function.

  • Binding Assays: Thermal shift assays (differential scanning fluorimetry) with candidate ligands may identify molecules that stabilize the protein, suggesting binding partners.

  • Genetic Approaches: Creating knockout mutants (ΔBLi01172/BL01343) in B. licheniformis and assessing phenotypic changes under various stress conditions (osmotic, heat, pH, antimicrobial exposure) can provide functional insights.

  • Proteomic Interaction Studies: Cross-linking followed by mass spectrometry or pull-down assays can identify protein interaction partners, clarifying the molecular context in which UPF0344 functions.

  • Electrophysiological Measurements: If channel activity is suspected, patch-clamp techniques on reconstituted systems can measure ion conductance and selectivity.

The combination of these approaches produces a comprehensive functional profile, particularly valuable for understudied membrane proteins like UPF0344.

How can CRISPR-Cas systems be utilized to study UPF0344 protein function in Bacillus licheniformis?

CRISPR-Cas technology offers powerful approaches for investigating UPF0344 protein function in B. licheniformis through genome editing and transcriptional regulation. The CRISPR/Cas9n gene editing system has demonstrated efficient gene modification capabilities in B. licheniformis, with reported efficiencies of 100% for single gene edits and 79.0% for large fragment modifications .

For studying UPF0344, researchers can implement:

  • Knockout Studies: Complete deletion of BLi01172/BL01343 genes to assess the resulting phenotype. Target design should account for potential polar effects if these genes are part of an operon.

  • Point Mutations: Creating specific amino acid substitutions at conserved residues to identify functionally critical domains. This approach is particularly valuable for transmembrane proteins where complete deletion may be lethal.

  • CRISPRi Approaches: Using a deactivated Cas9 (dCas9) system under mannose-inducible promoter control allows for tunable downregulation of gene expression without complete elimination. The mannose-induced CRISPRi system in B. licheniformis has demonstrated downregulation efficiency of up to 84% .

  • Promoter Replacement: Substituting the native promoter with characterized inducible promoters such as the xylose-inducible promoter allows for controlled expression studies. This approach can help determine whether the protein's function is essential under certain conditions.

The design of guide RNAs should consider the high GC content often found in B. licheniformis genes and potential off-target effects. Validating genomic modifications requires sequencing and comprehensive phenotypic characterization under various environmental conditions.

What approaches are most effective for studying membrane topology of UPF0344 protein?

Determining the membrane topology of UPF0344 protein requires multiple complementary experimental approaches:

  • Cysteine Scanning Mutagenesis: Systematically replacing residues with cysteine throughout the protein sequence, followed by accessibility assays using membrane-permeable and impermeable sulfhydryl reagents. This establishes which regions are exposed to either side of the membrane.

  • Fusion Reporter Techniques: Creating fusion constructs with reporter proteins (GFP, PhoA, or LacZ) at different positions can indicate cytoplasmic or extracellular localization based on reporter activity.

  • Protease Protection Assays: Limited proteolysis of membrane preparations followed by mass spectrometry analysis identifies accessible regions versus protected transmembrane domains.

  • FRET-Based Approaches: Using fluorescent protein pairs to measure distances between protein regions can validate predicted structural arrangements.

Table 3 presents a proposed experimental design for topology mapping:

RegionApproachExpected Result if CytoplasmicExpected Result if Extracellular
N-terminus (1-12)GFP fusionActive fluorescenceMinimal fluorescence
Loop 1 (35-42)PhoA fusionLow phosphatase activityHigh phosphatase activity
Loop 2 (66-75)Cysteine labelingLabeled only with permeable reagentsLabeled with all reagents
C-terminus (99-118)Protease susceptibilityProtectedDigested

Combined results from these approaches produce a definitive topological map that can inform structure-function relationship studies and guide protein engineering efforts.

How can researchers investigate the potential role of UPF0344 in antimicrobial resistance mechanisms?

B. licheniformis is known for producing various antimicrobial substances, including bacteriocins and non-ribosomally synthesized peptides . Investigating whether UPF0344 protein contributes to antimicrobial resistance or production mechanisms requires several specialized approaches:

  • Comparative Expression Analysis: Quantitative RT-PCR or RNA-seq comparing UPF0344 expression levels in wild-type strains versus strains exposed to antibiotics or competing microorganisms. Correlations between expression changes and resistance phenotypes may indicate functional involvement.

  • Protein-Antibiotic Interaction Studies: Surface plasmon resonance or isothermal titration calorimetry to detect direct binding between purified UPF0344 protein and various antibiotics.

  • Resistance Profiling: Determining minimum inhibitory concentrations (MICs) of various antimicrobials against wild-type, UPF0344 overexpression, and knockout strains. Significant changes in MIC values would suggest involvement in resistance mechanisms.

  • Metabolomic Analysis: Comparing metabolite profiles between wild-type and UPF0344 mutant strains may reveal alterations in antimicrobial compound production. This is particularly relevant given B. licheniformis' capacity to produce various antimicrobial compounds like bacteriocins .

  • Membrane Permeability Assays: Fluorescent dye uptake experiments can determine whether UPF0344 affects membrane permeability to antimicrobial compounds.

The experimental design should include appropriate controls and multiple B. licheniformis strains to account for strain-specific variations in antimicrobial production and resistance mechanisms.

What are the major challenges in crystallizing UPF0344 protein for structural analysis?

Crystallizing membrane proteins like UPF0344 presents significant challenges that require specialized approaches. The primary difficulties include:

  • Protein Stability: Maintaining the native conformation of UPF0344 outside its membrane environment requires careful detergent selection. Initial screening should include a panel of detergents (DDM, LMNG, OG, LDAO) at varying concentrations to identify optimal solubilization conditions.

  • Crystal Packing Limitations: The detergent micelle surrounding the hydrophobic transmembrane regions limits crystal contact formation. Techniques to overcome this include:

    • Using antibody fragments (Fab or nanobodies) to increase the hydrophilic surface area

    • Employing fusion partners like T4 lysozyme or BRIL in predicted loop regions

    • Utilizing lipidic cubic phase (LCP) crystallization methods

  • Conformational Heterogeneity: Membrane proteins often exhibit multiple conformations, hindering crystal formation. Stabilizing agents like lipids (specifically those found in B. licheniformis membranes) or potential ligands can reduce this heterogeneity.

  • Protein Production Scale: Obtaining sufficient quantities of pure, homogeneous protein requires large-scale expression. For UPF0344, yields can be improved by using strong constitutive promoters like PbacA or PalsSD in B. licheniformis expression systems .

Table 4 outlines a strategic approach to UPF0344 crystallization:

StageApproachScreening VariablesSuccess Indicators
Initial Detergent ScreeningThermal stability assays8-12 detergents, varying concentrationsΔTm > 5°C
Crystallization Method SelectionVapor diffusion vs. LCPpH range 5.5-8.0, PEG concentrationsMicrocrystal formation
Additive ScreeningLipids, small moleculesNative B. licheniformis lipids, potential substratesImproved crystal size
Crystal OptimizationSeeding, temperature variation18-25°C, various seeding protocolsDiffraction quality crystals

If crystallization proves challenging, alternative structural approaches like cryo-electron microscopy (cryo-EM) or nuclear magnetic resonance (NMR) for specific protein domains should be considered.

How can molecular dynamics simulations complement experimental studies of UPF0344 protein?

Molecular dynamics (MD) simulations provide valuable insights into UPF0344 protein behavior within membrane environments, complementing experimental approaches:

  • Membrane Integration Analysis: All-atom MD simulations can predict the stable orientation of UPF0344 within lipid bilayers, identifying preferred lipid interactions and membrane deformations. This is particularly valuable for membrane proteins where experimental determination of precise positioning is challenging.

  • Functional Mechanism Prediction: MD simulations can identify potential substrate binding sites and transport pathways by analyzing cavities, water-accessible regions, and electrostatic properties. For UPF0344, simulations may reveal channel-like features or substrate binding pockets not evident from sequence analysis alone.

  • Conformational Dynamics: Simulations on microsecond timescales can capture conformational changes relevant to function, particularly transitions between open and closed states if UPF0344 functions as a transporter or channel.

  • Mutation Impact Prediction: In silico mutations at conserved residues can predict functional impacts before experimental validation, guiding site-directed mutagenesis studies.

Simulation protocols should include:

  • Multiple replicate simulations (minimum 3) of sufficient duration (>100 ns each)

  • Testing in different membrane compositions, including B. licheniformis-like lipid environments

  • Enhanced sampling techniques (metadynamics, replica exchange) to explore rare conformational events

  • Validation against available experimental data on membrane protein behavior

MD simulations can generate testable hypotheses about UPF0344 function that direct subsequent experimental work, creating an iterative research cycle between computational prediction and experimental verification.

How does UPF0344 protein sequence conservation correlate with functional predictions across Bacillus species?

Evolutionary analysis of UPF0344 protein provides critical insights into functionally important regions and potential specialization across Bacillus species. Sequence conservation patterns reveal:

  • Core Conserved Domains: Multiple sequence alignment of UPF0344 homologs across Bacillus species identifies highly conserved residues, likely essential for structural integrity or function. These typically include specific glycine residues in transmembrane regions that provide flexibility and charged residues at membrane interfaces.

  • Species-Specific Variations: Regions showing higher variability between species may indicate adaptation to specific ecological niches or functional specialization. B. licheniformis, known for its ability to produce antimicrobial substances , may contain unique sequence features in UPF0344 compared to non-antimicrobial-producing species.

  • Coevolution Analysis: Statistical coupling analysis (SCA) or direct coupling analysis (DCA) can identify co-evolving residue pairs, suggesting physical interaction or functional coupling within the protein structure.

Table 5 presents a conservation analysis across selected Bacillus species:

RegionConservation LevelNotable FeaturesFunctional Hypothesis
N-terminus (1-12)ModerateVariable lengthSpecies-specific regulation
TM Helix 1 (13-34)HighG20, I22, L24 conservedStructural stability
Loop 1 (35-42)LowHighly variablePotential species adaptation
TM Helix 2 (43-65)Very HighF58, T61 conservedCore functional domain
Loop 2 (66-75)ModerateE70 conservedPotential substrate interaction
TM Helix 3 (76-98)HighG85, G89 conservedConformational flexibility
C-terminus (99-118)LowVariable length and sequenceSpecies-specific function

Phylogenetic analysis integrated with functional annotation of related species can further refine functional predictions. Proteins showing highest sequence similarity to UPF0344 in B. licheniformis from antimicrobial-producing species may suggest involvement in common cellular processes related to antimicrobial production or resistance.

What experimental approaches can validate computational predictions about UPF0344 protein function?

Bridging computational predictions with experimental validation requires a systematic approach:

The experimental design should include appropriate controls and multiple replicate experiments to ensure reproducibility. Results should be analyzed quantitatively using statistical methods appropriate for the specific experimental approach employed.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.